Impact of detectable measurable residual disease on umbilical cord blood transplantation-Reference-Cited by-同舟云学术

Impact of detectable measurable residual disease on umbilical cord blood transplantation

Published:2020-06-30 Issue:9 Volume:95 Page:1057-1065
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Baron Frédéric¹^ORCID,Labopin Myriam²³⁴⁵,Ruggeri Annalisa⁶⁷^ORCID,Sierra Jorge⁸,Robinson Stephen⁹,Labussière‐Wallet Hélène¹⁰,Potter Michael¹¹,Ribera Josep‐Maria¹²^ORCID,Deconinck Eric¹³,Rambaldi Alessandro¹⁴,Rohrlich Pierre‐Simon¹⁵,Revel Thierry¹⁶,Gluckman Eliane⁷,Nagler Arnon²¹⁷,Mohty Mohamad²³⁴⁵

Affiliation:

1. Laboratory of Hematology, GIGA‐I3 University of Liege and CHU of Liège Liege Belgium

2. EBMT Paris Study Office/CEREST‐TC Paris France

3. Service d'Hématologie Clinique et de Thérapie cellulaire APHP, Hôpital Saint Antoine Paris France

4. Centre de Recherche Saint‐Antoine (CRSA) INSERM Paris France

5. Sorbonne Université Paris France

6. Ospedale San Raffaele s.r.l., Haematology and BMT Milan Italy

7. Eurocord, Hospital Saint Louis, AP‐HP, and IUH University Paris VII, France; Monacord, Centre Scientifique de Monaco Monaco Monaco

8. Department of Hematology Hospital Santa Creu i Sant Pau Barcelona Spain

9. Department of Haematology Bristol Haematology Oncology Centre, University Hospital Bristol Bristol UK

10. Service Hematologie Centre Hospitalier Lyon Sud Lyon France

11. Royal Marsden Hospital Leukaemia Myeloma Units London UK

12. Department of Clinical Hematology ICO‐Hospital Universitari Germans Trias i Pujol Josep Carreras Research Institute Badalona Spain

13. Service d'Hématologie Hopital Jean Minjoz Besancon France

14. Department of Oncology and Hematology University of Milan and Azienda Socio Sanitaria Territoriale, Papa Giovanni XXIII Bergamo Italy

15. CHU Nice ‐ Hôpital de l'ARCHET I, Hematologie Clinique Nice France

16. Department of Hematology Hôpital Américain Clamart France

17. Division of Hematology and Bone Marrow Transplantation The Chaim Sheba Medical Center, Tel‐Hashomer Ramat‐Gan Israel

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25879

Reference44 articles.

1. Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients

2. Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio

3. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia

4. Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

5. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplant Outcomes in Myelofibrosis: Impact of Donor Type [Cord Blood Grafts Supported by CD34+ selected Cells (Haplo-Cord) vs Matched Donors];Transplantation and Cellular Therapy;2024-09

2. Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;American Journal of Hematology;2024-08-31

3. Measurable residual disease (MRD)-testing in haematological and solid cancers;Leukemia;2024-04-18

4. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study;British Journal of Haematology;2023-10-02

5. Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT;Bone Marrow Transplantation;2023-05-10